Patents by Inventor Robert Attwood

Robert Attwood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug eluting matrix on analyte indicator
    Patent number: 11672860
    Abstract: A sensor that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing and an analyte indicator covering at least a portion of the sensor housing. The sensor may include a drug-eluting matrix that covers at least a portion of the analyte indicator. The drug-eluting matrix may include one or more openings configured to allow the medium to pass through the drug-eluting matrix and come into contact with the analyte indicator. The sensor may include one or more therapeutic agents. The one or more therapeutic agents may reduce deterioration of the analyte indicator. The one or more therapeutic agents may be incorporated within the drug-eluting matrix.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: June 13, 2023
    Assignee: Senseonics, Incorporated
    Inventors: Philip Huffstetler, Sanat Mohanty, Robert Attwood
  • DRUG ELUTING MATRIX ON ANALYTE INDICATOR
    Publication number: 20200138948
    Abstract: A sensor that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing and an analyte indicator covering at least a portion of the sensor housing. The sensor may include a drug-eluting matrix that covers at least a portion of the analyte indicator. The drug-eluting matrix may include one or more openings configured to allow the medium to pass through the drug-eluting matrix and come into contact with the analyte indicator. The sensor may include one or more therapeutic agents. The one or more therapeutic agents may reduce deterioration of the analyte indicator. The one or more therapeutic agents may be incorporated within the drug-eluting matrix.
    Type: Application
    Filed: November 1, 2019
    Publication date: May 7, 2020
    Applicant: Senseonics, Incorporated
    Inventors: Philip Huffstetler, Sanat Mohanty, Robert Attwood